| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268892 | European Urology Focus | 2016 | 4 Pages |
Abstract
We investigated the relationship between levels of the drug target PDL1 before and after chemotherapy in patients with bladder cancer. We found that levels of PDL1 increased following chemotherapy. We conclude that this information may help doctors in optimizing the sequence of therapies in bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Andrew S. McDaniel, Ajjai Alva, Tianyu Zhan, Hong Xiao, Xuhong Cao, Amy Gursky, Javed Siddiqui, Arul M. Chinnaiyan, Hui Jiang, Cheryl T. Lee, Rohit Mehra,